← The SEC Ephemeris: the whole map
CELLTRION, Inc. Steqeyma
In the graph: all 6 documents (21 pages).
- Application
- BLA 761377
- Ticker
- CELLTRION, Inc.
- Product
- Steqeyma
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- March 26, 2025 · December 17, 2024 · September 30, 2024 · June 27, 2024 · March 30, 2018 · February 28, 2018
From FDA letters and SEC filings. Not investment or medical advice.